HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST LAIs) in Nigeria

ConditionHIV
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexMale
Age18+
SponsorGeorge Washington University

About this trial

Long-acting injectable antiretroviral therapy (LAI ART) and Pre-Exposure Prophylaxis (LAI PrEP) have the potential to transform HIV treatment and prevention, especially in reaching individuals such as commercial minibus drivers who have minimal or no contact with traditional health facilities. The project proposes to use a culturally appropriate and community-engaged approach to promote the uptake of HIV self-testing, LAI-ART, and LAI-PrEP among commercial minibus drivers in Nigeria by engaging commercial minibus drivers as peer educators/research facilitators.

Eligibility criteria

Qualifiers

Male commercial minibus drivers who have worked as a driver for at least 6 months

18 years old or older

Currently and planning on residing in one of the LGAs during the next 12 months

Owning a mobile phone

Disqualifiers

Known HIV positivity

Not ability to provide informed consent3

No access to a cell phone

Trial design

Treatments tested in this trial

  • ITEST-LAI

Treatment groups

400 Participants
are divided into 2 treatment groups

Sponsors and collaborators

George Washington University

Lead sponsor

The George Washington University Milken Institute School of Public Health (GWU)

Collaborator